MedPath

BRECKENRIDGE PHARMACEUTICAL, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

38

FDA:38

Drug Approvals

Ascomp with Codeine

Approval Date
Mar 18, 2024
FDA

Trimipramine Maleate

Approval Date
Mar 15, 2024
FDA

Granisetron Hydrochloride

Approval Date
Feb 29, 2024
FDA

Everolimus

Approval Date
Feb 23, 2024
FDA

Estradiol / Norethindrone Acetate

Approval Date
Feb 21, 2024
FDA

METHYLERGONOVINE MALEATE

Approval Date
Feb 20, 2024
FDA

EPLERENONE

Approval Date
Feb 15, 2024
FDA

Asenapine

Approval Date
Feb 13, 2024
FDA

Butalbital, Acetaminophen, Caffeine and Codeine Phosphate

Approval Date
Feb 8, 2024
FDA

Tetracycline Hydrochloride

Approval Date
Feb 8, 2024
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

FDA Approves Breckenridge's Methadone Hydrochloride Injection for Pain Management and Opioid Dependence

Breckenridge Pharmaceutical receives FDA approval for its Methadone Hydrochloride Injection USP, a multi-dose vial formulation.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy